Warning Letters Sent to Companies Illegally Selling OTC Skin Lightening Products
These OTC skin lightening products containing the active ingredient hydroquinone are not approved and are not generally recognized as safe and effective.
These OTC skin lightening products containing the active ingredient hydroquinone are not approved and are not generally recognized as safe and effective.
Two cases documented in patients taking hydroquinone at a concentration of 7 to 10 percent
Confetti-like depigmentation may be a marker of rapidly progressing vitiligo.
Researchers report that a drug for rheumatoid arthritis may be a promising treatment for vitiligo.
The prevalence of atopic dermatitis (AD) is higher among patients with vitiligo or alopecia areata (AA), according to new research.
Cosmetic camouflage can improve quality of life in children and adolescents with visible vascular and pigmentary anomalies.
Teledermatology is reliable for initial triage of patients, according to a study published online.
Botanical extracts may be helpful in the treatment of hyperpigmentation, although identification of hyperpigmentation subtype may be important for treatment prognosis.
Three-dimensional (3D) high precision surface imaging can be used to monitor changes in the area and volume of port wine stains following laser treatment.
Galderma announced that Tri-Luma (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) cream is available again for short-term treatment (up to 8 weeks) of moderate to severe melasma of the face, in the presence of measures for sun avoidance, including the use of sunscreens.